10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG)

346 filings reported holding TXG - 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share as of Q4 2020.
10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG) has 300 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 66.2M shares of 114M outstanding shares and own 57.89% of the company stock.
Largest 10 shareholders include FMR LLC (10.1M shares), MORGAN STANLEY (6.71M shares), VANGUARD GROUP INC (6.19M shares), BlackRock Inc. (5.16M shares), Meritech Capital Associates V L.L.C. (2.58M shares), Foresite Capital Management II, LLC (2.5M shares), 12 West Capital Management LP (1.92M shares), Venrock Management VI, LLC (1.89M shares), AMERIPRISE FINANCIAL INC (1.37M shares), and WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1.28M shares).
This table shows the top 300 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.